Important announcement

The current page will cease to exist as of June 2019. Data, information and documents related to our grants are now available on the Global Fund Data Explorer. Please use this platform.


Malawi has made significant progress in the fight against HIV, tuberculosis and malaria. The total number of people receiving antiretroviral therapy increased from 3,000 in 2003 to 679,050 by December 2016. The national HIV program has made great strides in responding to its HIV epidemic: nearly three-quarters of adults living with HIV were aware of their status. Among adults living with HIV who know their HIV status, 89 percent self-report current use of ART. Among these, 91 percent have their HIV virus suppressed. TB treatment success rate reached 81 percent by the end of 2016. There has also been a steady decrease in reported malaria cases. Malawi continues to show leadership in domestic financing for health, having increased health expenditure to almost US$40 million for HIV, TB and malaria.

However, challenges remain. Health systems are fragile and the country continues to face severe staffing shortages in the health sector and has few resources to meet a minimal level of health care. HIV prevalence remains high, with 9.1 percent of the adult population living with HIV. TB continues to be a significant public health problem and malaria is among the major causes of illness and death.

View data on: Data Explorer


For documents pertaining to a specific grant, please select a grant from the list.

Country Results Profiles